Health and Fitness Health and Fitness
Tue, September 18, 2012
Mon, September 17, 2012
[ Mon, Sep 17th 2012 ] - Market Wire
Imaging3 Files Chapter 11
[ Mon, Sep 17th 2012 ] - Market Wire
illumigene®; Group A Strep

Synergetics USA Announces Conference Call to Review Fourth Quarter and Fiscal Year 2012 Results


Published on 2012-09-17 11:15:38 - Market Wire
  Print publication without navigation


September 17, 2012 13:36 ET

Synergetics USA Announces Conference Call to Review Fourth Quarter and Fiscal Year 2012 Results

O'FALLON, MO--(Marketwire - Sep 17, 2012) - Synergetics USA, Inc. (NASDAQ: [ SURG ]) announced today that it will release summary financial results for the fourth quarter and the fiscal year 2012 before the market opens on Monday, October 1, 2012. At 9:30 a.m. Central Time (10:30 a.m. Eastern) of that day the Company will host a conference call to discuss financial results for its fourth fiscal quarter and fiscal year, ended July 31, 2012.

During the call, David Hable, Synergetics' President and Chief Executive Officer, and Pamela G. Boone, Executive Vice President and Chief Financial Officer, will provide an overview of the fourth quarter and fiscal 2012 performance and business highlights. A question and answer session will follow prepared remarks.

The toll free dial-in number to participate live on this call is (800) 588-4973, confirmation code 33288783. For callers outside the U.S., the number is (847) 230-5643. The conference call will also be available live via webcast at [ http://www.synergeticsusa.com ]. A replay will be available on the Company's website for approximately 30 days.

About Synergetics USA, Inc.
Synergetics USA, Inc. ("Synergetics USA" or the "Company") is a leading supplier of precision surgical devices. The Company's primary focus is on the surgical disciplines of ophthalmology and neurosurgery. Our distribution channels include a combination of direct and independent sales organizations and important strategic alliances with market leaders. The Company's product lines focus upon precision engineered, disposable and reusable devices, procedural kits, and the delivery of various energy modalities for the performance of less invasive surgery including: (i) laser energy, (ii) ultrasonic energy, (iii) radio frequency for electrosurgery and lesion generation and (iv) visible light energy for illumination, and where applicable, simultaneous infusion (irrigation) of fluids into the operative field. The Company's website address is [ http://www.synergeticsusa.com ].

Forward-Looking Statements

Some statements in this release may be "forward-looking statements" for the purposes of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified by words such as "believe," "expect," "anticipate," "plan," "potential," "continue" or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks and uncertainties are discussed in Synergetics' Annual Report on Form 10-K for the year ended July 31, 2011, as updated from time to time in our filings with the Securities and Exchange Commission.


Contributing Sources